Episode 24016
Tiny RNAs, Big Cures!!! Dr. Sanjay Shukla, President and CEO, ATyr (ah-tire) Pharma
BioTech Nation ... with Dr. Moira Gunn · Moira Gunn
April 17, 202419m 54s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week - Dr. Sanjay Shukla, CEO of Atyr Pharma, discusses the revolutionary potential of mRNA technology in creating new medicines. They explore Atyr's pioneering approach to leveraging tRNA fragments for treating pulmonary sarcoidosis and other organ-specific conditions, aiming to improve patient outcomes while minimizing reliance on conventional therapies like steroids.
Topics
mRNAtechnologyAtyr PharmaDr. Sanjay ShuklaDNAmRNA vaccinestRNAprotein synthesisDr. Paul Schimmelimmunologypulmonary sarcoidosisPhase 3 trialsorgan-specific conditionsinnovative therapiessteroidspatient outcomes